Proteomics

Dataset Information

0

Huma Multiple Myeloma Cell line, AMO1, treated with NCP26, LC-MSMS analysis


ABSTRACT: The human multiple myeloma cell line, AMO1, was treated with NCP26, an ATP-competitive EPRS inhibitor, and a total proteome-wide analysis was performed to determine the effect of NCP26 treatment on protein dynamics.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Plasma Cell, Multiple Myeloma Cell Line

DISEASE(S): Multiple Myeloma

SUBMITTER: Keiji Kurata  

LAB HEAD: Kenneth Carl Anderson

PROVIDER: PXD029453 | Pride | 2023-03-11

REPOSITORIES: Pride

altmetric image

Publications


Multiple myeloma (MM) is a plasma cell malignancy characterised by aberrant production of immunoglobulins requiring survival mechanisms to adapt to proteotoxic stress. We here show that glutamyl-prolyl-tRNA synthetase (GluProRS) inhibition constitutes a novel therapeutic target. Genomic data suggest that GluProRS promotes disease progression and is associated with poor prognosis, while downregulation in MM cells triggers apoptosis. We developed NCP26, a novel ATP-competitive ProRS inhibitor that  ...[more]

Similar Datasets

2020-03-02 | PXD017424 | Pride
2021-09-09 | PXD022860 | Pride
2021-09-09 | PXD022349 | Pride
2019-10-30 | PXD015358 | Pride
2022-03-01 | PXD009232 | Pride
2023-06-09 | PXD041952 | Pride
2019-09-30 | PXD012285 | Pride
2018-08-06 | PXD008660 | Pride
2022-01-14 | PXD028092 | Pride
2015-09-17 | PXD001297 | Pride